Invention Grant
- Patent Title: Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
-
Application No.: US17127530Application Date: 2020-12-18
-
Publication No.: US11702664B2Publication Date: 2023-07-18
- Inventor: Robert Petit , Michael F. Princiotta
- Applicant: ADVAXIS, INC.
- Applicant Address: US NJ Princeton
- Assignee: Advaxis, inc.
- Current Assignee: Advaxis, inc.
- Current Assignee Address: US NJ Princeton
- Agency: Alston & Bird LLP
- Main IPC: C12N15/74
- IPC: C12N15/74 ; A61P35/00 ; A61K39/00 ; A61K35/74 ; C07K14/00 ; C12P21/02 ; C07K14/195 ; C07K14/82 ; A61K38/00 ; A61K39/12
Abstract:
This disclosure provides compositions, including Listeria delivery vectors comprising minigene expression constructs, and methods of using the same for inducing an immune response against an antigen-expressing tumor and for treating the same, and vaccinating against the same in subjects bearing the tumors.
Public/Granted literature
- US20210246457A1 Listeria-Based Compositions Comprising a Peptide Minigene Expression System and Methods of Use Thereof Public/Granted day:2021-08-12
Information query
IPC分类:
